YC-backed Opalite Health hires founding GTM lead to scale AI medical interpretation
The Winter 2026 startup aims to replace traditional healthcare interpretation services with a real-time voice AI system.
Opalite Health, a member of the Y Combinator Winter 2026 batch, is recruiting its first Go-To-Market lead to establish its enterprise sales motion. The startup is developing a voice AI system for real-time medical interpretation designed to integrate directly into existing clinical workflows.
The founding GTM role is tasked with breaking into hospitals and health systems to transition these institutions from traditional interpretation services to a software-based model. According to Y Combinator, the position offers a base salary of $70,000, supplemented by uncapped commission and an equity stake ranging from 0.10% to 0.30%.
The Friction of Medical Translation
Language barriers in healthcare settings frequently result in delayed care and increased operational costs for providers. Historically, health systems have relied on human interpretation services, which can be slow to deploy or unavailable around the clock. By providing an instant, software-driven alternative, Opalite Health seeks to reduce these overhead costs while simultaneously improving accessibility for non-English speaking patients.
Scaling AI in Clinical Settings
The intersection of generative AI and healthcare represents one of the fastest-growing sectors in technology. Opalite Health, founded by Alex Mehregan and Cathleen Kuo, MD, is targeting a specific friction point—medical interpretation—to prove that a scalable AI model can replace human-dependent services. If successful, this shift could significantly lower the administrative burden on hospitals and improve health outcomes for marginalized patient populations by ensuring accurate, immediate communication.
The Path to Enterprise Adoption
As the company moves from development to market entry, the focus shifts to the complexities of healthcare procurement. The new GTM lead will be responsible for navigating the long sales cycles typical of large health systems and demonstrating the reliability of AI in high-stakes medical environments. Observers will be watching to see how effectively Opalite can integrate its voice AI into the rigid infrastructure of modern hospitals and whether health systems are ready to trust software over human interpreters for critical patient care.